<DOC>
	<DOCNO>NCT02838784</DOCNO>
	<brief_summary>This study compare proportion patient wound closure within 12 week well time wound closure patient receive Artacent™ versus standard care treatment non-healing low extremity wound . The recurrence heal wound assess 6 month via telephone survey</brief_summary>
	<brief_title>Efficacy Safety Artacent™ Treatment Resistant Lower Extremity Venous Diabetic Ulcers</brief_title>
	<detailed_description>This study document efficacy Artacent™ Human Amniotic Membrane ( Artacent ) treatment diabetic vascular lower extremity ulcer . The study add currently available literature also assess impact treatment quality life heal economic outcome . Finally study follow patient longer previous study obtain data heal recurrence 6 month . The objective study 1 ) compare Artacent standard care ( SOC ) treatment non-healing low extremity ulcer 2 ) evaluate impact treatment patient quality life . Health economic outcome also collect . The proportion patient receive Artacent wound closure 12 week compare patient receive SOC compare . A comparison time wound closure also compare two population . Patients randomized SOC group ( control ) require treatment 12 week due incomplete wound healing , may receive treatment Artacent investigator determines potentially beneficial option .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<criteria>Age 18 year older Able willing give consent comply study Lower extremity ulcer 1 25 cm2 point 4 week runin period Has receive document SOC treatment 4 week great duration result &lt; 50 % reduction ulcer size No clinical sign infection ulcer site Serum Creatinine 3.0 mg/dl Serum HgA1c 12 % Adequate circulation affect limb ABI 0.7 1.2 tri/biphasic arterial waveform ankle affected leg . Is participate another wound study Has Charcot foot Has previously receive different biological graft target foot Has one low extremity ulcer Has ulcer probe bone involve tendon , muscle , joint capsule sinus tract Is currently receive radiation chemotherapy Has autoimmune connective tissue disorder Is take medication know immune system modulator Is pregnant consider become pregnant within next 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>